Peel Hunt reaffirmed their buy rating on shares of CVS Group (LON:CVSG) in a report published on Friday, March 29th, ThisIsMoney.Co.Uk reports.
Separately, Royal Bank of Canada cut shares of CVS Group to a sector performer rating and reduced their price target for the stock from GBX 1,180 ($15.42) to GBX 600 ($7.84) in a research report on Wednesday, January 30th.
Shares of CVSG traded down GBX 2 ($0.03) during mid-day trading on Friday, hitting GBX 588 ($7.68). 259,790 shares of the company’s stock were exchanged, compared to its average volume of 234,115. The stock has a market capitalization of $413.95 million and a PE ratio of 62.55. CVS Group has a fifty-two week low of GBX 362.40 ($4.74) and a fifty-two week high of GBX 1,191 ($15.56). The company has a debt-to-equity ratio of 83.39, a quick ratio of 0.89 and a current ratio of 1.13.
In other news, insider Richard A. Connell purchased 10,000 shares of the business’s stock in a transaction dated Wednesday, January 30th. The stock was acquired at an average price of GBX 407 ($5.32) per share, with a total value of £40,700 ($53,181.76).
About CVS Group
CVS Group plc engages in veterinary, online pharmacy, and retail businesses. The company operates through four segments: Veterinary Practice, Laboratory, Crematoria, and Animed Direct. It operates animal veterinary practices and complementary veterinary diagnostic businesses. The company also provides pet cremation services for veterinary practices and directly for pet owners; and clinical waste collection services, as well as specialist veterinary recruitment services.
See Also: Systematic Risk
Receive News & Ratings for CVS Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Group and related companies with MarketBeat.com's FREE daily email newsletter.